Endocrine And Metabolic Diseases Flashcards
What is type 1 diabetes?
An autoimmune disease in which the immune system mediates the destruction of beta-cells.
Which HLA is associated with type 1 DM?
HLA-DQ
HLA-DR2 and DR4
What is the criteria to diagnose type 2 DM?
- Random: >200 (11.1) and patient is symptomatic
- Fasting: >126 (7) on 2 occasions
- 2 -hr postprandial: >200 (11.1) on 2 occasions
- HbA1c: >6.5
What is the criteria to diagnose pre-diabetes or Impaired Glucose Tolerance?
- Fasting BG: 110-126 (5.6-6.9)
- 2-hr postprandial: 140-200 (7.7-11.1)
- HbA1c: 5.7-6.4
What is the criteria for screening DM?
- Started from age of 35 and older, if results are normal repeat within 3 years or earlier depending on risk factors and lab result levels
- Started earlier than 35 year old if patient is overweight or obese with an additional risk factor for T2DM
- Pre-diabetes should be repeated yearly
- Women with gestational diabetes should repeat every 3 years
- HIV infection
What are the general principles of outpatient management and monitoring of all diabetic patients?
- Monitor HbA1c every 3-4 months, not recommended if patient has hemoglobinopathies
- Monitor daily glycemic levels especially if on insulin therapy: before meals, 90-120 minutes after meal and at bedtime
- Screen for microalbuminurea at least once per year, if positive give ACE inhibitor or ARB
- Check BUN, creatinine, urine albumin:creatinine ratio once per year
- Eye screening once per year
- Check the feet at every visit
- Check cholesterol level once per year, give statins if LDL is >100
- Check BP at every visit
- Daily aspirin
- Vaccine
What are the goal levels of microalbumin, BP and lipids?
Microalbumin: < 30 mg/g
BP: <140/90 mmHg
LDL: <70
HDL: >40 in males, >50 in females
Triglycerides: <150
What is the recommended pharmacological treatment for diabetic with high ASCVD risk or high risk individual?
SGLT2 (empagliflozin) or GLP-1 (liraglutide)
What is the recommended pharmacological treatment for diabetic with heart failure?
SGLT-2 (empagliflozin)
What is the recommended pharmacological treatment for patient with CKD?
SGLT-2 (empagliflozin), but if not tolerated or contraindicated GLP-1 can be used instead
What is preprandial and postprandial glycemic target?
Preprandial: <130 (7.2)
Postprandial: <180 (10)
What are the indications for insulin therapy in T2DM?
- If patient’s glycemic targets are not met despite sufficient anti-diabetic treatment
- If patient has contraindications for non-insulin anti-diabetic drugs
- Pregestational and gestational diabetes
- Hyperglycemia crisis
- Newly diagnosed patients with:
- Initial glucose >300 mg/dL or HbA1c >10%
- Symptoms of hyperglycemia
- Signs of a continued catabolic state, e.g. weight loss
What is the amount of basal insulin given in T2DM?
0.2-0.3 units/kg
What is the amount of insulin required in T1DM to achieve glycemic control?
0.5-1 unit/kg per day, divided into 50% basal and 50% prandial insulin
What is the most common cause of death in diabetic patients?
CAD
What are the macrovascular complications of DM?
- Coronary artery disease
- Peripheral vascular disease
- Cerebrovascular disease
What are the microvascular complications of DM?
- Diabetic nephropathy
- Diabetic retinopathy
- Diabetic neuropathy
- Diabetic foot
- Increased susceptibility to infection
What are the key features of DKA?
- Hyperglycemia (>450 mg/dL and <850 mg/dL)
- Positive serum or urine ketones
- Metabolic acidosis (pH <7.3 and HCO3 <18 mEq/L)
How DKA managed?
- Insulin priming dose of 0.1 units/kg of regular insulin (IV) followed by infusion of 0.1 units/kg/hr. BUT withhold insulin if potassium is <3.3 mEq/L, give 20-30 mEq/hr of potassium and once it has reached 3.3-5.2 mEq/L then give insulin
- Fluid replacement of 1L/hr 0.9% saline infusion for the first 2 hours and then 0.5L/hr. Add 5% glucose once blood glucose reaches 200 mg/dL to prevent hypoglycemia.
How is Hyperosmolar Hyperglycemic Nonketotic Syndrome diagnosed?
- Hyperglycemia >900 mg/dL
- Hyperosmolarity >320 mOsm/L
- No acidosis
How is HHNS managed?
- Fluid replacement: 1L in the first hour and another liter in the next 2 hours
- Insulin: check potassium levels before initiating insulin, initial bolus of 0.1 units/kg as IV bolus and then continuous low-dose infusion 0.1 units/kg/hr
What is the most common cause of hyperprolactinemia?
Prolactinoma
What are the clinical features of hyperprolactinemia in men?
- Hypogonadism, decreased libido, infertility, impotence
- Galactorrhea or gynecomastia
- Parasellar signs and symptoms
What are the clinical features of hyperprolactinemia in women?
Premenopausal:
- Menstrual irregularities, oligomenorrhea or amenorrhea, anovulation and infertility, decreased libido, dyspareunia, vaginal dryness, risk of osteoporosis, galactorrhea
Postmenopausal:
- Parasellar signs and symptoms
How can hyperprolactinemia cause such clinical features relate to estrogen and testosterone?
High levels of prolactin inhibits secretion of GnRH which leads to decreased secretion of LH and FSH that in turn leads to decreased production of estrogen and testosterone.
How is hyperprolactinemia diagnosed?
- Elevated serum prolactin level (>200 NT/mL)
- Order pregnancy test and TSH level to r/o other causes of hyperprolactinemia
- CT scan or MRI to identify any mass lesions
How is Prolactinoma treated?
- Bromocriptine or cabergoline for 2 years
- Surgery if symptoms progress despite medical therapy